Risk assessment and primary VTE prevention in the cancer patient.
Levine
Mark N
MN
McMaster University, Faculty of Health Sciences, Hamilton, Canada. mlevine@mcmaster.ca
Lee
Agnes Y Y
AY
D000925:Anticoagulants / Q000627:therapeutic use; D002405:Catheterization, Central Venous / Q000009:adverse effects; D003131:Combined Modality Therapy / Q000009:adverse effects; D006801:Humans; D009369:Neoplasms / Q000150:complications* / Q000628:therapy; D011183:Postoperative Complications; D018570:Risk Assessment; D013923:Thromboembolism / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control; D020246:Venous Thrombosis / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control*
D000925:Anticoagulants